BiotechTube

inhaled corticosteroid plus LABA plus oral corticosteroid

ApprovedCompleted
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

ASTHMA

Conditions

ASTHMA

Trial Timeline

Dec 9, 2005 โ†’ May 13, 2009

NCT ID
NCT01089322

About inhaled corticosteroid plus LABA plus oral corticosteroid

inhaled corticosteroid plus LABA plus oral corticosteroid is a approved stage product being developed by Rafael Holdings for ASTHMA. The current trial status is completed. This product is registered under clinical trial identifier NCT01089322. Target conditions include ASTHMA.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01089322ApprovedCompleted

Competing Products

20 competing products in ASTHMA

See all competitors
ProductCompanyStageHype Score
RoflumilastAstraZenecaPhase 3
77
DuleraMerckApproved
85
BriquilimabJasper TherapeuticsPhase 1
25
YHD001 dose level 1 + YHD001 dose level 2 + Singulair + PlaceboYuhanPhase 2
52
RoflumilastAstraZenecaPhase 3
77
OmalizumabDaiichi SankyoPhase 3
77
OmalizumabDaiichi SankyoPhase 3
77
Tacrolimus Inhalation AerosolAstellas PharmaPhase 2
52
Regadenoson + PlaceboAstellas PharmaApproved
85
TacrolimusAstellas PharmaPhase 2
52
tacrolimusAstellas PharmaPhase 2
52
Zero-dose + 90 mcg of PROAIRยฎ HFA + 180 mcg of 90 mcg of PROAIRยฎ HFA + 90 mcg of albuterol sulfate inhalation aerosolSun PharmaceuticalPhase 3
77
rabeprazoleEisaiPhase 3
77
KHK4563 + KHK4563 + KHK4563 + PlaceboKyowa KirinPhase 2
52
Placebo + BrodalumabKyowa KirinPhase 2
52
ONO-6950 + ONO-6950 + Montelukast + PlaceboOno PharmaceuticalPhase 2
52
ONO-6950 + Placebo + MontelukastOno PharmaceuticalPhase 2
52
Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation) + Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1 + Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2 + PlaceboCiplaPhase 3
77
Budesonide 80 ฮผg and Formoterol Fumarate Dihydrate 4.5 ฮผg + Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol + PlaceboCiplaPhase 3
77
90 mcg Reference Product + 180 mcg Reference Product + 90 mcg Test Product + PlaceboCiplaPhase 3
77

Other Products from Rafael Holdings

Varenicline + Nicotine patchApproved
77
Polyethylene glycol 4000 + Macrogol 3350 plus ascorbic acidApproved
77
IV trivalent saccharose hydroxide ferrous + Oral ferrous fumarate + Oral and intravenous PlaceboApproved
77
Insulin + insulinApproved
77
Tacrolimus with rapid steroid withdrawal + Tacrolimus with steroids minimization + CsA with steroid minimizationApproved
77